Paul Scott Thorner

Paul Scott Thorner

Auto-generated profile, based on publicly available information

Paul Scott Thorner

Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2020 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
PDF file
CCCatherine T. Chung
Catherine T. Chung
CACristina R. Antonescu
Cristina R. Antonescu
BDBrendan C. Dickson
Brendan C. Dickson
RCRose Chami
Rose Chami
PMPaula Marrano
Paula Marrano
PTPaul S. Thorner
Paul S. Thorner

Verified
Journal Article
Open access
PDF file
PCPiya Chaemsaithong
Piya Chaemsaithong
SLSuchaya Luewan
Suchaya Luewan
MTMana Taweevisit
Mana Taweevisit
WCWararat Chiangjong
Wararat Chiangjong
PPPisut Pongchaikul
Pisut Pongchaikul
SCSomchai Chutipongtanate
Somchai Chutipongtanate
Extracellular vesicles (EVs) are nano-scaled vesicles released from all cell types into extracellular fluids and specifically contain signature molecules of the original cells and tissues, including the placenta. Placenta-derived EVs can be detected in maternal circulation at as early as six weeks of gestation, and their release can be triggered by the oxygen level and glucose concentration. Placental-associated complications such as preeclampsia, fetal growth restriction, and gestational diabetes have alterations in placenta-derived EVs in maternal plasma, and this can be used as a liquid biopsy for the diagnosis, prediction, and monitoring of such pregnancy complications. Alpha-thalassemia major (“homozygous alpha-thalassemia-1”) or hemoglobin Bart’s disease is the most severe form of thalassemia disease, and this condition is lethal for the fetus. Women with Bart’s hydrops fetalis demonstrate signs of placental hypoxia and placentomegaly, thereby placenta-derived EVs provide an opportunity for a non-invasive liquid biopsy of this lethal condition. In this article, we introduced clinical features and current diagnostic markers of Bart’s hydrops fetalis, extensively summarize the characteristics and biology of placenta-derived EVs, and discuss the challenges and opportunities of placenta-derived EVs as part of diagnostic tests for placental complications focusing on Bart’s hydrop fetalis.

20 November 2019 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
PDF file
KDKai Duan
Kai Duan
BDBrendan C. Dickson
Brendan C. Dickson
PMPaula Marrano
Paula Marrano
PTPaul S. Thorner
Paul S. Thorner
CCCatherine T. Chung
Catherine T. Chung

1 July 2010 in Pediatric and Developmental Pathology
Verified
Journal Article
Closed access
KCKenneth Tou-En Chang
Kenneth Tou-En Chang
NCNeil K. Chadha
Neil K. Chadha
RLRichard Leung
Richard Leung
MSMary Shago
Mary Shago
MPM. James Phillips
M. James Phillips
PTPaul S. Thorner
Paul S. Thorner
Lymphadenoma of the salivary gland is a rare benign tumor with only 11 reported cases in the English language literature, most of which have occurred in adults. We report a case of a lymphadenoma occurring in the parotid gland of a 15-year-old girl. The tumor was composed of variably sized cystic cavities within abundant reactive lymphoid tissue. The cystic spaces were filled with eosinophilic secretions with occasional histiocytes. Many of these features were also apparent on cytologic preparations. The cysts were lined by epithelium lacking atypia and showed luminal and abluminal differentiation both by immunohistochemistry and by electron microscopy. Tumor cells were not cycling as determined by MIB1 immunostaining, and the tumor karyotype was normal. This is only the second case to be reported in the pediatric age group. Ultrastructural features and karyotype analysis are reported for the first time. Although this tumor is rarely encountered by pediatric pathologists, awareness of its existence is important to distinguish it from possible malignant mimics, such as lymphoepithelial carcinoma and metastatic mucoepidermoid carcinoma in a lymph node.

1 September 2019 in American Journal of Surgical Pathology
Verified
Journal Article
Closed access
RCRose Chami
Rose Chami
PMPaula Mlt Marrano
Paula Mlt Marrano
CTChinachote Teerapakpinyo
Chinachote Teerapakpinyo
AAAnthony Arnoldo
Anthony Arnoldo
MSMary Shago
Mary Shago
PTPaul S. Thorner
Paul S. Thorner
Neuroblastoma is the most common extracranial solid tumor of childhood with a median age of presentation of 17 months. A common theme in high-risk neuroblastoma is maintenance of telomeres, one mechanism for which involves alternate lengthening of telomeres (ALT) associated withATRXgene mutations. Mutations are believed to result in loss of ATRX protein, and therefore immunohistochemistry is used to detect mutations. We screened 133 cases of neuroblastoma by ATRX immunohistochemistry, and found 9 cases with partial to total absence of ATRX. Sequencing forATRXmutations detected a mutation in 1 of 9 cases, suggesting immunostaining was not reliable for detecting mutations. To correlate immunostaining with ALT, fluorescence in situ hybridization (FISH) for ALT was performed in 6 of these cases and 5 (from 4 patients) showed ALT, implying impaired ATRX protein function, despite the failure to identify a mutation. Two other cases with large deletions in theATRXgene showed diffusely positive staining for ATRX protein but showed ALT by FISH. Four of the 6 patients with ALT-positive tumors were over 5 years old. Therefore, 29 additional patients 5 years old and above with ATRX-positive tumors were screened for ALT by FISH and 6 additional cases with ALT were detected, bringing the total to 29% (10/34) of children 5 years old and above, 70% of which showed positive ATRX immunohistochemistry. Patients withATRXmutations in neuroblastoma tend to have a more chronic and progressive course of disease. Screening neuroblastoma tumors at diagnosis forATRXmutations may help identify patients who might benefit from personalized therapy directed against ALT. However, relaying on negative immunohistochemistry for ATRX protein to identify ALT in neuroblastoma may miss a significant proportion of patients. The addition of FISH for ALT as part of the diagnostic workup, especially for older children (5 y old and above), would help ensure that patients are correctly identified for anti-ALT therapy.

10 April 2023 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
ABAtthaporn Boongird
Atthaporn Boongird
NLNopphon Lekcharoensombat
Nopphon Lekcharoensombat
AJArtit Jinawath
Artit Jinawath
TTTalent Theparee
Talent Theparee
NJNutchawan Jittapiromsak
Nutchawan Jittapiromsak
CTChinachote Teerapakpinyo
Chinachote Teerapakpinyo